Bank of New York Mellon »

Rapport Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $409k 20k 20.48